MTRR and ovarian carcinoma: In addition, elevated expression of the oncogenic promoter methionine synthase reductase (MTRR) has been found in ovarian cancer, and cisplatin resistance can be inhibited by inhibiting MTRR expression which can reduce autophagy [41].